Clinical Trials Browser

Phase 1/2 × OTHER_GOV × Meningeal Carcinomatosis × Clear all

NCT07264569 2025-12-04

Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001

Phase 1/2 Recruiting

Meningeal Carcinomatosis